Showing results (1531-1540 of 6,713) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|June 22, 2018
Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AMLEvan C Chen, Amir T Fathi, Andrew M BrunnerOncotargets and Therapy|February 6, 2015
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategiesFrancesco Spagnolo, Paola Ghiorzo, Laura Orgiano, et al.Oncotargets and Therapy|February 6, 2015
HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinomaYou-You Xia, Li Yin, Hao Tian, et al.Oncotargets and Therapy|February 6, 2015
Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastasesQi Lin, Ye Wei, Li Ren, et al.Oncotargets and Therapy|June 13, 2014
Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapyHongqing Zhuang, Hailing Hou, Zhiyong Yuan, et al.Oncotargets and Therapy|June 13, 2014
Prevalence and relationship between major depressive disorder and lung cancer: a cross-sectional studyBenchalak Maneeton, Narong Maneeton, Jirayu Reungyos, et al.Oncotargets and Therapy|June 13, 2014
Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenibKwong-Ming Kee, Chao-Hung Hung, Jing-Houng Wang, et al.Oncotargets and Therapy|June 13, 2014
Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancersJingxu Sun, Yongxi Song, Zhenning Wang, et al.Oncotargets and Therapy|June 14, 2014
Cyclic adenosine monophosphate-responsive element-binding protein activation predicts an unfavorable prognosis in patients with hepatocellular carcinomaLingxiang Yu, Xiaodong Guo, Peirui Zhang, et al.Oncotargets and Therapy|May 24, 2014
Transcriptional targeting of sphingosine-1-phosphate receptor S1P2 by epigallocatechin-3-gallate prevents sphingosine-1-phosphate-mediated signaling in macrophage-differentiated HL-60 promyelomonocytic leukemia cellsRima Chokor, Sylvie Lamy, Borhane AnnabiPageof 672